Xiaoru Feng

Ms. Xiaoru Feng

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
XFXiaoru Feng
Xiaoru Feng
ZLZeqi Liu
Zeqi Liu
XHXiaotong He
Xiaotong He
XWXibiao Wang
Xibiao Wang
CYChangzheng Yuan
Changzheng Yuan
YWYou Wu
You Wu
(1) Background: Studies have reported that COVID-19 may increase the risk of malnutrition among patients. However, the prevalence of such risk in hospitalized COVID-19 patients is uncertain due to the inconsistent use of assessment methods. (2) Methods: PubMed, Web of Science, and EMBASE were searched to identify studies on the nutritional status of hospitalized COVID-19 patients. A pooled prevalence of malnutrition risk evaluated by Nutrition Risk Score (NRS-2002) was obtained using a random effects model. Differences by study-level characteristics were examined by hospitalization setting, time of assessment, age, and country. Risk of bias was assessed using the Newcastle–Ottawa Scale. (3) Results: 53 studies from 17 countries were identified and summarized. A total of 17 studies using NRS-2002, including 3614 COVID-19 patients were included in the primary meta-analysis. The pooled prevalence of risk of malnutrition was significantly higher among ICU patients (92.2%, 95% CI: 85.9% to 96.8%) than among general ward patients (70.7%, 95% CI: 56.4% to 83.2%) (p = 0.002). No significant differences were found between age groups (≥65 vs. <65 years, p = 0.306) and countries (p = 0.893). (4) Conclusions: High risk of malnutrition is common and concerning in hospitalized patients with COVID-19, suggesting that malnutrition screening and nutritional support during hospitalization are needed.

14 August 2024 in Asia-Pacific Journal of Ophthalmology
Verified
Journal Article
Open access
XFXiaoru Feng
Xiaoru Feng
KXKezheng Xu
Kezheng Xu
MLMing-Jie Luo
Ming-Jie Luo
HCHaichao Chen
Haichao Chen
YYYangfan Yang
Yangfan Yang
DLDennis Shun-Chiu Lam
Dennis Shun-Chiu Lam
The emergence of generative artificial intelligence (AI) has revolutionized various fields. In ophthalmology, generative AI has the potential to enhance efficiency, accuracy, personalization and innovation in clinical practice and medical research, through processing data, streamlining medical documentation, facilitating patient-doctor communication, aiding in clinical decision-making, and simulating clinical trials. This review focuses on the development and integration of generative AI models into clinical workflows and scientific research of ophthalmology. It outlines the need for development of a standard framework for comprehensive assessments, robust evidence, and exploration of the potential of multimodal capabilities and intelligent agents. Additionally, the review addresses the risks in AI model development and application in clinical service and research of ophthalmology, including data privacy, data bias, adaptation friction, over interdependence, and job replacement, based on which we summarized a risk management framework to mitigate these concerns. This review highlights the transformative potential of generative AI in enhancing patient care, improving operational efficiency in the clinical service and research in ophthalmology. It also advocates for a balanced approach to its adoption.

20 February 2025 in Obesity
Verified
Journal Article
Closed access
XFXiaoru Feng
Xiaoru Feng
RLRuoqian Li
Ruoqian Li
HYHang Yi
Hang Yi
SCShuyi Chen
Shuyi Chen
MLMeng Liu
Meng Liu
YWYou Wu
You Wu

4 September 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
XFXiaoru Feng
Xiaoru Feng
RLRuoqian Li
Ruoqian Li
MYMinqing Yan
Minqing Yan
CYChangzheng Yuan
Changzheng Yuan
YWYou Wu
You Wu
Background: Liver cancer is a significant disease burden, with metabolic factors potentially influencing its risk. Diabetics, due to metabolic abnormalities, may be more sensitive to environmental exposures. Beverages like tea and alcohol could impact liver cancer risk and may influence prevention in diabetics. Methods: This study included 30,289 diabetics and 482,292 non-diabetics aged 30–79 years from the China Kadoorie Biobank. Baseline alcohol and tea consumption during the past year was collected through questionnaires, including frequency, amount, duration, and types. Incident liver cancer cases were identified from the national health insurance system and local disease registries. Cox proportional hazards regression models estimated hazard ratios (HRs) and 95% confidence intervals (CIs). Results: During a median follow-up of 9.6 years for diabetics and 10.1 years for non-diabetics, 193 (0.69 cases/1000 person-years) and 398 (0.45 cases/1000 person-years) incident liver cancer cases were documented, respectively. Weekly alcohol consumption was associated with higher liver cancer risk in both groups, stronger in diabetics (HR = 1.62; 95% CI: 1.12, 2.34) than in non-diabetics (HR = 1.20, 95% CI: 1.07, 1.35). Among diabetics, the risk was higher in some weekly alcohol consumption subgroups: high-level intake (HR = 2.21; 95% CI: 1.28, 3.80), ≥30 years (HR = 1.70; 95% CI: 1.06, 2.71), or spirit (≥50% alcohol) alcohol-specific consumption (HR = 1.91; 95% CI: 1.20, 3.04), and these associations were stronger than those in non-diabetics. For weekly tea consumption, low-level intake (HR = 0.82; 95% CI: 0.68, 0.99), <10 years (HR = 0.74; 95% CI: 0.58, 0.93), 10–29 years (HR = 0.84; 95% CI: 0.71, 0.99), and green tea-specific consumption (HR = 0.86; 95% CI: 0.75, 0.98) were associated with reduced liver cancer risk in non-diabetics. However, these associations were not significant in those with diabetes. Conclusions: Weekly alcohol consumption is significantly associated with an increased risk of liver cancer, especially in diabetics, while tea consumption appears to lower risk only in non-diabetics, highlighting the need for alcohol reduction in diabetics.

24 January 2025 in Health Care Science
Verified
Journal Article
Open access
XFXiaoru Feng
Xiaoru Feng
YSYu Sun
Yu Sun
YWYou Wu
You Wu
HWHaibo Wang
Haibo Wang
YWYang Wu
Yang Wu

11 November 2025 in Optics Express
Verified
Journal Article
Closed access
MCMingHui Chen
MingHui Chen
WXWeiJie Xing
WeiJie Xing
XFXiaoru Feng
Xiaoru Feng
Chang ChenChang Chen
Chang Chen
LZLin Zhou
Lin Zhou
YWYou Wu
You Wu
Knowledge of site-specific skin characteristics is important for optimizing multiple µ-spatially offset Raman spectroscopy (mµSORS)-based glucose monitoring. We characterized the thenar skin characteristics of 120 patients with type 2 diabetes mellitus (T2DM) and 20 healthy volunteers to support the development of mµSORS. We assessed the skin thickness, optical attenuation coefficient (OAC), surface roughness, skin hydration, sebum on skin surface, and color, and the distributions of the values were characterized. The skin of the patients had a thicker stratum corneum ( p = 0.02) and a more undulating dermal–epidermal junction ( p = 0.05) than that of the controls. Analyses of the relationship between parameters for the T2DM group revealed that: (1) the epidermal thickness and stratum spinosum OAC were significantly associated with skin lightness and saturation; (2) the skin thickness, OAC, and surface roughness varied significantly with age and sex, especially the upper dermis OAC. These findings constitute valuable data for the optimization of mµSORS-based non-invasive glucose monitoring and offer insight into the skin characteristics of patients with diabetes.